FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1972425341> ?p ?o ?g. }

• W1972425341 endingPage "1746" @default.
• W1972425341 startingPage "1740" @default.
• W1972425341 abstract "ObjectiveTo determine the effects of high-dose vitamin D on insulin sensitivity in polycystic ovary syndrome (PCOS).DesignRandomized, placebo-controlled trial.SettingAcademic medical center.Patient(s)Twenty-eight women with PCOS.Intervention(s)Vitamin D3, 12,000 IU, or placebo daily for 12 weeks.Main Outcome Measure(s)The primary outcome was quantitative insulin sensitivity check index. Secondary outcomes included glucose and insulin levels during a 75-g oral glucose tolerance test and blood pressure.Result(s)Twenty-two women completed the study. Compared with placebo, vitamin D significantly increased 25-hydroxyvitamin D (mean [95% confidence interval] in vitamin D group 20.1 [15.7 to 24.5] ng/mL at baseline and 65.7 [52.3 to 79.2] ng/mL at 12 weeks; placebo 22.5 [18.1 to 26.8] ng/mL at baseline and 23.8 [10.4 to 37.2] ng/mL at 12 weeks). There were no significant differences in quantitative insulin sensitivity check index and other measures of insulin sensitivity; however, we observed trends toward lower 2-hour insulin and lower 2-hour glucose. We also observed a protective effect of vitamin D on blood pressure.Conclusion(s)In women with PCOS, insulin sensitivity was unchanged with high-dose vitamin D, but there was a trend toward decreased 2-hour insulin and a protective effect on blood pressure.Clinical Trial Registration NumberNCT00907153. To determine the effects of high-dose vitamin D on insulin sensitivity in polycystic ovary syndrome (PCOS). Randomized, placebo-controlled trial. Academic medical center. Twenty-eight women with PCOS. Vitamin D3, 12,000 IU, or placebo daily for 12 weeks. The primary outcome was quantitative insulin sensitivity check index. Secondary outcomes included glucose and insulin levels during a 75-g oral glucose tolerance test and blood pressure. Twenty-two women completed the study. Compared with placebo, vitamin D significantly increased 25-hydroxyvitamin D (mean [95% confidence interval] in vitamin D group 20.1 [15.7 to 24.5] ng/mL at baseline and 65.7 [52.3 to 79.2] ng/mL at 12 weeks; placebo 22.5 [18.1 to 26.8] ng/mL at baseline and 23.8 [10.4 to 37.2] ng/mL at 12 weeks). There were no significant differences in quantitative insulin sensitivity check index and other measures of insulin sensitivity; however, we observed trends toward lower 2-hour insulin and lower 2-hour glucose. We also observed a protective effect of vitamin D on blood pressure. In women with PCOS, insulin sensitivity was unchanged with high-dose vitamin D, but there was a trend toward decreased 2-hour insulin and a protective effect on blood pressure." @default.
• W1972425341 created "2016-06-24" @default.
• W1972425341 creator A5013411486 @default.
• W1972425341 creator A5046674807 @default.
• W1972425341 creator A5046678065 @default.
• W1972425341 creator A5048319992 @default.
• W1972425341 creator A5059117544 @default.
• W1972425341 creator A5077144143 @default.
• W1972425341 creator A5085666129 @default.
• W1972425341 date "2014-06-01" @default.
• W1972425341 modified "2023-10-18" @default.
• W1972425341 title "High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial" @default.
• W1972425341 cites W1968912276 @default.
• W1972425341 cites W1991736636 @default.
• W1972425341 cites W1994204510 @default.
• W1972425341 cites W2004147182 @default.
• W1972425341 cites W2028048632 @default.
• W1972425341 cites W2030892848 @default.
• W1972425341 cites W2037986775 @default.
• W1972425341 cites W2057301426 @default.
• W1972425341 cites W2079725498 @default.
• W1972425341 cites W2090263177 @default.
• W1972425341 cites W2096717361 @default.
• W1972425341 cites W2096887626 @default.
• W1972425341 cites W2099094363 @default.
• W1972425341 cites W2121201490 @default.
• W1972425341 cites W2126327417 @default.
• W1972425341 cites W2131909681 @default.
• W1972425341 cites W2154698068 @default.
• W1972425341 cites W2171750463 @default.
• W1972425341 doi "https://doi.org/10.1016/j.fertnstert.2014.02.021" @default.
• W1972425341 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4537163" @default.
• W1972425341 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24636395" @default.
• W1972425341 hasPublicationYear "2014" @default.
• W1972425341 type Work @default.
• W1972425341 sameAs 1972425341 @default.
• W1972425341 citedByCount "58" @default.
• W1972425341 countsByYear W19724253412015 @default.
• W1972425341 countsByYear W19724253412016 @default.
• W1972425341 countsByYear W19724253412017 @default.
• W1972425341 countsByYear W19724253412018 @default.
• W1972425341 countsByYear W19724253412019 @default.
• W1972425341 countsByYear W19724253412020 @default.
• W1972425341 countsByYear W19724253412021 @default.
• W1972425341 countsByYear W19724253412022 @default.
• W1972425341 countsByYear W19724253412023 @default.
• W1972425341 crossrefType "journal-article" @default.
• W1972425341 hasAuthorship W1972425341A5013411486 @default.
• W1972425341 hasAuthorship W1972425341A5046674807 @default.
• W1972425341 hasAuthorship W1972425341A5046678065 @default.
• W1972425341 hasAuthorship W1972425341A5048319992 @default.
• W1972425341 hasAuthorship W1972425341A5059117544 @default.
• W1972425341 hasAuthorship W1972425341A5077144143 @default.
• W1972425341 hasAuthorship W1972425341A5085666129 @default.
• W1972425341 hasBestOaLocation W19724253411 @default.
• W1972425341 hasConcept C124490489 @default.
• W1972425341 hasConcept C126322002 @default.
• W1972425341 hasConcept C134018914 @default.
• W1972425341 hasConcept C142724271 @default.
• W1972425341 hasConcept C168563851 @default.
• W1972425341 hasConcept C204787440 @default.
• W1972425341 hasConcept C27081682 @default.
• W1972425341 hasConcept C2776940978 @default.
• W1972425341 hasConcept C2777391703 @default.
• W1972425341 hasConcept C2778901321 @default.
• W1972425341 hasConcept C2779306644 @default.
• W1972425341 hasConcept C3017594256 @default.
• W1972425341 hasConcept C3018442814 @default.
• W1972425341 hasConcept C71924100 @default.
• W1972425341 hasConcept C84393581 @default.
• W1972425341 hasConceptScore W1972425341C124490489 @default.
• W1972425341 hasConceptScore W1972425341C126322002 @default.
• W1972425341 hasConceptScore W1972425341C134018914 @default.
• W1972425341 hasConceptScore W1972425341C142724271 @default.
• W1972425341 hasConceptScore W1972425341C168563851 @default.
• W1972425341 hasConceptScore W1972425341C204787440 @default.
• W1972425341 hasConceptScore W1972425341C27081682 @default.
• W1972425341 hasConceptScore W1972425341C2776940978 @default.
• W1972425341 hasConceptScore W1972425341C2777391703 @default.
• W1972425341 hasConceptScore W1972425341C2778901321 @default.
• W1972425341 hasConceptScore W1972425341C2779306644 @default.
• W1972425341 hasConceptScore W1972425341C3017594256 @default.
• W1972425341 hasConceptScore W1972425341C3018442814 @default.
• W1972425341 hasConceptScore W1972425341C71924100 @default.
• W1972425341 hasConceptScore W1972425341C84393581 @default.
• W1972425341 hasIssue "6" @default.
• W1972425341 hasLocation W19724253411 @default.
• W1972425341 hasLocation W19724253412 @default.
• W1972425341 hasLocation W19724253413 @default.
• W1972425341 hasLocation W19724253414 @default.
• W1972425341 hasOpenAccess W1972425341 @default.
• W1972425341 hasPrimaryLocation W19724253411 @default.
• W1972425341 hasRelatedWork W138803513 @default.
• W1972425341 hasRelatedWork W1835582227 @default.
• W1972425341 hasRelatedWork W192964961 @default.
• W1972425341 hasRelatedWork W1986132654 @default.
• W1972425341 hasRelatedWork W2010140898 @default.
• W1972425341 hasRelatedWork W2020998291 @default.

• next